BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1466152)

  • 1. Cystatin C in the human pancreas and gut: an immunohistochemical study of normal and neoplastic tissues.
    Lignelid H; Jacobsson B
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(6):491-5. PubMed ID: 1466152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
    Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
    J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical localization of human kallikreins 6 and 10 in pancreatic islets.
    Petraki CD; Karavana VN; Revelos KI; Luo LY; Diamandis EP
    Histochem J; 2002; 34(6-7):313-22. PubMed ID: 12769263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours.
    Stridsberg M; Oberg K; Li Q; Engström U; Lundqvist G
    J Endocrinol; 1995 Jan; 144(1):49-59. PubMed ID: 7891024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin-dependent kinase (cdk6) and p16 in pancreatic endocrine neoplasms.
    Tomita T
    Pathology; 2004 Dec; 36(6):566-70. PubMed ID: 15841692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of seven neuroendocrine markers in pancreatic endocrine tumours.
    Bordi C; Pilato FP; D'Adda T
    Virchows Arch A Pathol Anat Histopathol; 1988; 413(5):387-98. PubMed ID: 2845642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone receptor immunoreactivity in pancreatic endocrine tumors. An immunocytochemical study of 156 neuroendocrine tumors of the pancreas, gastrointestinal and respiratory tracts, and skin.
    Viale G; Doglioni C; Gambacorta M; Zamboni G; Coggi G; Bordi C
    Cancer; 1992 Nov; 70(9):2268-77. PubMed ID: 1356613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amylin in pancreatic islets and pancreatic endocrine neoplasms.
    Tomita T
    Pathol Int; 2003 Sep; 53(9):591-5. PubMed ID: 14507315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of p53 immunoreactivity in pancreatic endocrine tumors.
    Lee CS
    Pathology; 1996 May; 28(2):139-41. PubMed ID: 8743819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ localization of transthyretin-mRNA in the adult human liver, choroid plexus and pancreatic islets and in endocrine tumours of the pancreas and gut.
    Jacobsson B
    Histochemistry; 1989; 91(4):299-304. PubMed ID: 2659558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma.
    Oue N; Mitani Y; Aung PP; Sakakura C; Takeshima Y; Kaneko M; Noguchi T; Nakayama H; Yasui W
    J Pathol; 2005 Oct; 207(2):185-98. PubMed ID: 16086444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut hormone secreting tumours.
    Wood SM; Polak JM; Bloom SR
    Scand J Gastroenterol Suppl; 1983; 82():165-79. PubMed ID: 6314485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PGP 9.5 immunocytochemical staining for pancreatic endocrine tumors.
    Tomita T
    Islets; 2013; 5(3):122-8. PubMed ID: 23959334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of peptide receptors in human endocrine tumours of the pancreas.
    Tang C; Biemond I; Lamers CB
    Gut; 1997 Feb; 40(2):267-71. PubMed ID: 9071943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of antibodies against human prealbumin to intestinal and bronchial carcinoids and to pancreatic endocrine tumours.
    Bussolati G; Papotti M; Sapino A
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1984; 45(1):15-22. PubMed ID: 6142557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transthyretin in endocrine pancreatic tumors.
    Jacobsson B; Carlström A; Collins VP; Grimelius L
    Am J Pathol; 1989 Feb; 134(2):465-71. PubMed ID: 2464944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular heterogeneity of glucagon in normal subjects and in patients with glucagon-producing tumours.
    Holst JJ
    Diabetologia; 1983 May; 24(5):359-65. PubMed ID: 6307793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgical treatment of neuroendocrine tumours of the pancreas].
    Farkas G
    Magy Onkol; 2003; 47(4):345-7. PubMed ID: 14716428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functioning human insulinomas. An immunohistochemical analysis of intracellular insulin processing.
    Azzoni C; D'Adda T; Tamburrano G; Coscelli C; Madsen OD; Scopsi L; Bordi C
    Virchows Arch; 1998 Dec; 433(6):495-504. PubMed ID: 9870681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Majority and minority cell populations in GEP and bronchial endocrine tumours.
    Sundler F; Alumets J; Håkanson R
    Scand J Gastroenterol Suppl; 1979; 53():9-13. PubMed ID: 225792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.